Summary#
This bill would require the United States Postal Service (USPS) to keep selling the Alzheimer's semipostal stamp for six more years. The stated goal is to give the public a convenient way to raise money for medical research on Alzheimer’s disease. The bill mostly keeps existing rules for semipostal stamps but changes how this particular stamp is treated under one legal limit.
- Main change: Continue sale of the Alzheimer's semipostal stamp for a six-year period starting on the date the Postal Service would otherwise have stopped selling it.
- Proceeds: Money raised by the stamp’s extra charge (the surcharge) must be transferred to the National Institutes of Health (NIH) and paid at least twice a year for the purpose described in existing law (research relating to Alzheimer’s disease).
- Legal treatment: During the six-year period, the stamp is treated as issued under this bill rather than under the usual semipostal law. That means it does not count toward an existing limit on how many semipostal stamps may be offered at the same time.
- Rules mostly unchanged: Except for the items above, sale and handling of the stamp are governed by the current law and USPS rules for semipostal stamps.
- What is unclear: The bill does not say the exact calendar start date; it starts on the date USPS would have discontinued sales without the bill. The bill does not include an estimate of how much money the stamp will raise or what administrative costs will be.
What it means for you#
- Stamp buyers and collectors
- You can keep buying the Alzheimer's semipostal stamp for six more years if the bill becomes law.
- Each stamp includes a surcharge above postage; that extra money supports Alzheimer’s research through NIH.
- People concerned about Alzheimer’s research
- This extends one channel for public donations to NIH-directed Alzheimer’s research.
- The bill does not change how NIH decides to use the money beyond the purpose stated in existing law.
- United States Postal Service
- USPS must continue manufacturing, selling, accounting for, and transmitting proceeds from this stamp for the extra six years.
- The bill exempts this stamp from the usual limit on how many semipostal stamps can be sold at once.
- National Institutes of Health
- NIH will receive the surcharge funds, with payments at least twice yearly.
- How NIH allocates the funds follows the existing directions in law.
- General public / taxpayers
- The surcharge is paid by stamp buyers, not directly by taxpayers. Any broader budget effects are not identified in the bill text or materials provided.
Expenses#
No publicly available information.
- The bill requires transferring stamp surcharge proceeds to NIH; the amount depends on how many stamps sell.
- The source material does not include a fiscal note or estimate of expected revenue from stamp sales.
- The bill does not provide an estimate of USPS administrative or accounting costs to continue selling the stamp.
- This could mean small operational costs for USPS (production, sales, bookkeeping), but the text gives no numbers.
Proponents' View#
- The bill appears intended to give the public an easy way to support Alzheimer’s research by keeping a popular fundraising stamp on sale.
- Supporters may argue that extending sales will increase funding available to NIH for research on Alzheimer’s disease.
- Keeping the stamp available could maintain public awareness about Alzheimer’s and sustain a steady fundraising channel without creating a new program.
- Treating this stamp separately from the usual semipostal limit could allow continued sale even if other semipostal stamps are introduced.
Opponents' View#
- One concern is the lack of a public fiscal estimate: the bill does not say how much money the stamp is likely to raise or what administrative costs USPS will incur.
- The bill exempts the stamp from the existing limit on concurrent semipostal stamps; this raises questions about whether it could crowd out or complicate fundraising for other causes.
- It is unclear exactly when the six-year extension starts, because the start date depends on when USPS would have stopped sales without the bill.
- The bill does not add oversight details or reporting requirements for how NIH uses the funds beyond the existing law, so transparency about spending levels or program effects is not increased by this text.